Ever wondered if Procter & Gamble could be a good value buy right now? With so much chatter about big consumer brands, it is smart to dig deeper and see what the numbers really say.

The stock has seen some ups and downs lately, with a dip of 2.0% over the last week and a year-to-date return of -12.2%. Its three- and five-year returns remain positive at 15.2% and 16.3%, respectively.

Recent news around inflationary pressures and shifting consumer spending patterns has sparked renewed debate on how resilient household staples like Procter & Gamble can be. Market watchers continue to weigh whether these broader trends actually create opportunities for long-term investors or signal heightened risk in the near future.

When it comes to valuation, Procter & Gamble scores a 3 out of 6 on our checks for being undervalued, which you can see for yourself here. Let's break down what this score really means, explore all the valuation angles, and hint at a more insightful approach that just might change how you look at stock value by the end of the article.

Procter & Gamble delivered -7.1% returns over the last year. See how this stacks up to the rest of the Household Products industry.

The Discounted Cash Flow (DCF) model works by forecasting a company's future cash flows and then discounting them back to their present value, giving a sense of what the business is actually worth based on its ability to generate cash over time.

Procter & Gamble's most recent annual Free Cash Flow stands at around $15.4 billion, reflecting a solid foundation of cash generation. Analyst projections see this figure climbing steadily, reaching approximately $16.98 billion in 2028, with Simply Wall St extrapolating further growth beyond that period. These growth estimates rest on assumptions about revenue and cost trends, with analyst forecasts running through to 2028 and extrapolations out to 2035. All cash flows referenced are in US dollars.

Based on these cash flow projections and the 2 Stage Free Cash Flow to Equity model, the resulting intrinsic value per share is estimated to be $186.25. With this methodology, the analysis points to the stock being 21.7% undervalued compared to its current share price. This indicates there may be notable upside for long-term investors who believe these forecasts are reasonable.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Procter & Gamble is undervalued by 21.7%. Track this in your watchlist or portfolio, or discover 836 more undervalued stocks based on cash flows.

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Procter & Gamble.

The Price-to-Earnings (PE) ratio is a favored valuation tool for profitable companies like Procter & Gamble because it directly aligns a company’s current share price with its actual earning power. This makes it especially meaningful for established businesses generating consistent profits, as investors want to know how much they are paying for each dollar of earnings.

Not all PE ratios are equal. The “right” ratio often depends on growth prospects and risk. Higher expected growth or lower risk justifies a higher PE, since investors anticipate greater future earnings. Conversely, if a company faces uncertainties or limited growth potential, a lower PE is more appropriate.

Currently, Procter & Gamble trades at a PE of 20.7x. This is a bit above both the Household Products industry average of 17.9x and the peer average of 20.4x. On the surface, this could look a little expensive, but context matters.

This is where the Simply Wall St “Fair Ratio” concept comes in. The Fair Ratio, calculated specifically for Procter & Gamble, is 25.8x. Unlike basic peer or industry comparisons, the Fair Ratio incorporates factors like expected earnings growth, profit margins, risk profile, and even company size. This gives a far more tailored benchmark for what Procter & Gamble’s PE should reasonably be.

Comparing the Fair Ratio of 25.8x to the company’s current PE of 20.7x suggests Procter & Gamble is trading below what would be justified by its fundamentals. In other words, the stock could be considered undervalued by this measure.

Result: UNDERVALUED

PE ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1402 companies where insiders are betting big on explosive growth.

Earlier we mentioned that there is an even better way to understand valuation, so let's introduce you to Narratives. A Narrative is like telling your own story about a company; it is your perspective on what drives the business, underpinned by your assumptions for fair value, future revenue, profit margins, and growth. Narratives connect the current facts about Procter & Gamble, such as its market position or growth strategy, to a financial forecast and ultimately to your own estimate of fair value.

On Simply Wall St's Community page, Narratives are easy to create and compare, used by millions of investors worldwide. They help you decide when to buy or sell by showing if your Fair Value (based on your Narrative) is above or below the current share price. Whenever new earnings, news, or events emerge, Narratives dynamically update to reflect the latest data, ensuring your view always stays relevant.

For Procter & Gamble, Narratives might range from a cautious outlook with a fair value as low as $119.81 (based on slow growth and margin pressure) all the way up to a bullish scenario targeting $186.00 (assuming stronger revenue and profitability). This means investors can see the full spectrum of market expectations and quickly spot if today’s price fits their own story.

For Procter & Gamble, we will make it straightforward for you with previews of two leading Procter & Gamble Narratives:

???? Procter & Gamble Bull Case

Fair Value: $169.05

Undervalued by 13.75%

Revenue Growth: 3.19%

Analysts expect innovation and operational improvements to drive moderate revenue and margin growth. This supports a fair value above today’s price.

Despite economic and geopolitical risks, productivity initiatives and global market expansion are seen as long-term growth drivers.

The current analyst consensus price target is about 7% above the recent share price. This suggests the stock may be fairly to modestly undervalued.

???? Procter & Gamble Bear Case

Fair Value: $119.81

Overvalued by 21.73%

Revenue Growth: 4.68%

P&G is a stable dividend giant. However, long-term growth is expected to remain modest, closely tracking inflation and the risk-free rate.

Using multiple valuation models, the estimated fair value is significantly below the current share price. This points to potential overvaluation.

The company’s premium valuation leaves limited upside unless unexpected margin expansion or revenue surprises occur. It remains a reliable dividend payer.

Do you think there's more to the story for Procter & Gamble? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include PG.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com